Hypoglycaemia with oral antidiabetic drugs: Results from Prescription-Event Monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide

Abstract

This study quantifies the incidence of hypoglycaemic events and describe the pattern of these incident events during first nine months of treatment with four oral antidiabetic drugs.